Journal
FRONTIERS IN IMMUNOLOGY
Volume 9, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2018.02675
Keywords
sirtuin; innate immunity; cytokine; macrophage; endotoxemia; sepsis; histone deacetylase; metabolism
Categories
Funding
- Swiss National Science Foundation (SNSF) [145014, 149511, 173123]
- Santos Suarez Foundation
- European Sepsis Academy Horizon 2020 Marie SklodowskaCurie Action: Innovative Training Network (MSCA-ESA-ITN) [676129, 12462]
- Porphyrogenis Foundation
Ask authors/readers for more resources
Sirtuin 5 (SIRT5) is a member of the family of NAD(+)-dependent lysine/histone deacetylases. SIRT5 resides mainly in the mitochondria where it catalyzes deacetylation, demalonylation, desuccinylation, and deglutarylation of lysine to regulate metabolic and oxidative stress response pathways. Pharmacologic inhibitors of SIRT5 are under development for oncologic conditions, but nothing is known about the impact of SIRT5 on antimicrobial innate immune defenses. Using SIRT5 knockout mice, we show that SIRT5 deficiency does not affect immune cell development, cytokine production and proliferation by macrophages and splenocytes exposed to microbial and immunological stimuli. Moreover, preclinical models suggest that SIRT5 deficiency does not worsen endotoxemia, Klebsiella pneumoniae and Streptococcus pneumoniae pneumonia, Escherichia coli peritonitis, listeriosis, and staphylococcal infection. Altogether, these data support the safety profile in terms of susceptibility to infections of SIRT5 inhibitors under development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available